Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study

被引:6
|
作者
Huang, Guang-Ming [1 ]
Qiu, Yue [1 ]
Liu, Tao-Tao [1 ]
Lu, Jie-Jiu [1 ]
机构
[1] Guangxi Med Univ, Dept Pharm, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 62卷 / 07期
基金
中国国家自然科学基金;
关键词
augmented renal clearance; critically ill infant; normal renal function; population pharmacokinetics; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; PEDIATRIC-PATIENTS; TROUGH CONCENTRATIONS; FEBRILE NEUTROPENIA; CYTOKINES; EXPOSURE; CHILDREN; OUTCOMES;
D O I
10.1002/jcph.2029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Augmented renal clearance presents as super-renal function with enhanced renal perfusion and glomerular hyperfiltration in many critically ill infants. This study was to compare vancomycin clearance (CL) between critically ill infants with augmented renal clearance and with normal renal function and to optimize the vancomycin dosage. Data were retrospectively obtained from infants treated in intensive care units. Population pharmacokinetics analysis was conducted using nonlinear mixed-effects model software. A total of 66 critically ill infants were included: 47 infants with augmented renal clearance and 19 infants with normal renal function. The median doses of vancomycin for infants with augmented renal clearance and with normal renal function were 48 and 47 mg/kg/day (P > .05), respectively. The median CL in infants with augmented renal clearance was increased 1.96-fold compared with infants who had normal renal function (0.98 versus 0.5 L/h, P < .001). Simulations indicated that the recommended dosage of 60, 70, 80, 90, and 100 mg/kg/day would be appropriate in critically ill infants with an estimated glomerular filtration rate (eGFR) of 130-149, 150-169, 170-189, 190-209, and >210 mL/min/1.73 m(2), respectively. Doses of 70 and 75 mg/kg/day were recommended for infants with augmented renal clearance and gestational ages of 27-32.9 and 33-39 weeks, respectively. Doses of 70, 75, 80, and 90 mg/kg/day were recommended for infants with augmented renal clearance and weights of 2.0-2.9, 3.0-3.9, 4.0-4.9, and 5.0-6.0 kg, respectively. In conclusion, the typical vancomycin dosage is insufficient for critically ill infants with augmented renal clearance. Premature infants and infants of low weight with augmented renal clearance need individualized dosing regimens to obtain an adequate area under the serum concentration time curve over 24 h/minimum inhibitory concentration ratio.
引用
下载
收藏
页码:863 / 872
页数:10
相关论文
共 50 条
  • [31] Augmented renal clearance: a common condition in critically ill children
    Van der Heggen, Tatjana
    Dhont, Evelyn
    Peperstraete, Harlinde
    Delanghe, Joris R.
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter A.
    PEDIATRIC NEPHROLOGY, 2019, 34 (06) : 1099 - 1106
  • [32] Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children
    Lv, Chun-Le
    Lu, Jie-Jiu
    Chen, Ming
    Zhang, Ren
    Li, Qiao-Chuan
    Chen, Yi-Yu
    Liu, Tao-Tao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1278 - 1287
  • [33] Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
    Bilbao-Meseguer, Idoia
    Barrasa, Helena
    Asin-Prieto, Eduardo
    Alarcia-Lacalle, Ana
    Rodriguez-Gascon, Alicia
    Maynar, Javier
    Angel Sanchez-Izquierdo, Jose
    Balziskueta, Goiatz
    Sanchez-Bayton Griffith, Maria
    Quilez Trasobares, Nerea
    Angeles Solinis, Maria
    Isla, Arantxa
    PHARMACEUTICS, 2021, 13 (10)
  • [34] Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children
    Evelyn Dhont
    Tatjana Van Der Heggen
    Evelien Snauwaert
    Jef Willems
    Siska Croubels
    Joris Delanghe
    Jan J. De Waele
    Roos Colman
    Johan Vande Walle
    Peter De Paepe
    Pieter A. De Cock
    Pediatric Nephrology, 2024, 39 : 1607 - 1616
  • [35] Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children
    Dhont, Evelyn
    Van der Heggen, Tatjana
    Snauwaert, Evelien
    Willems, Jef
    Croubels, Siska
    Delanghe, Joris
    De Waele, Jan J.
    Colman, Roos
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter A.
    PEDIATRIC NEPHROLOGY, 2024, 39 (05) : 1607 - 1616
  • [36] SCOPING REVIEW OF AUGMENTED RENAL CLEARANCE (ARC) IN THE CRITICALLY ILL ONCOLOGY PATIENT POPULATION
    Nelson, Nicholas
    Mendoza, Chelsea
    Rhoney, Denise
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 300 - 300
  • [37] A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment
    Tang, Lian
    Ding, Xin-yuan
    Duan, Lu-fen
    Li, Lan
    Lu, Hao-di
    Zhou, Feng
    Shi, Lu
    Lu, Jian
    Shen, Yi
    Zhuang, Zhi-wei
    Sun, Jian-tong
    Zhou, Qin
    Zhu, Chen-qi
    Li, Jing-jing
    Yu, Yan-xia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Drug Utilization in Critically Ill Adults with Augmented Renal Clearance Compared to Normal Renal Clearance: Implications for use of Anti-microbials with Predominant Renal Excretion
    Sridharan, Kannan
    Pasha, Sheikh A. A.
    Qader, Ali M.
    Hasan, Hasan M. S. N.
    El Seirafi, Mohamed M.
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (02) : 174 - 181
  • [39] Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance
    Fatma Hefny
    Sukhvir Sambhi
    Cassidy Morris
    Janice Y. Kung
    Anna Stuart
    Sherif Hanafy Mahmoud
    European Journal of Drug Metabolism and Pharmacokinetics, 2022, 47 : 607 - 620
  • [40] Scoping review of augmented renal clearance in critically ill pediatric patients
    Rhoney, Denise H.
    Metzger, Samuel A.
    Neslon, Nicholas R.
    PHARMACOTHERAPY, 2021, 41 (10): : 851 - 863